Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Cash Flow Quality Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Cash Flow Quality Index of 1.48x as of December 2024. Operating cash flow of CN¥116.38 Million exceeds net income of CN¥78.85 Million, indicating high earnings quality where cash backs reported profits. Explore 301033 cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 301033 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year earnings quality comparison for Medprin Regenerative Medical Technologies Co. Ltd.. For live market cap and the full company financial profile, see 301033 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.48x | CN¥116.38 Million | CN¥78.85 Million | ▼ -44.0% |
| 2023 | 2.63x | CN¥107.69 Million | CN¥40.88 Million | ▲ +95.7% |
| 2022 | 1.35x | CN¥48.31 Million | CN¥35.89 Million | ▼ -9.5% |
| 2021 | 1.49x | CN¥66.51 Million | CN¥44.73 Million | ▲ +62.1% |
| 2020 | 0.92x | CN¥33.91 Million | CN¥36.97 Million | ▼ -18.8% |
| 2019 | 1.13x | CN¥31.27 Million | CN¥27.68 Million | — |